Abstract
The Community for Open Antimicrobial Drug Discovery aims to tap into the potential of the millions of compounds distributed around laboratories globally to be a source of new antibiotic leads by offering free screening for antimicrobial properties, with no strings attached.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Nonribosomal antibacterial peptides isolated from Streptomyces agglomeratus 5-1-3 in the Qinghai-Tibet Plateau
Microbial Cell Factories Open Access 06 January 2023
-
Isolation and identification of endophytic actinobacteria from Citrullus colocynthis (L.) Schrad and their antibacterial properties
Microbial Cell Factories Open Access 10 October 2022
-
An appraisal of natural products active against parasitic nematodes of animals
Parasites & Vectors Open Access 17 June 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cooper, M. A. & Shlaes, D. A. Fix the antibiotics pipeline. Nature, 472, 32 (2011).
Payne, D. J. et al. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6, 29–40 (2007).
Lewis, K. Platforms for antibiotic discovery. Nat. Rev. Drug Discov. 12, 371–387 (2013).
Shushko, I. et al. ToxAlerts: a web server of structural alerts for toxic chemicals and compounds with potential adverse reactions. J. Chem. Inf. 52, 2310–2316 (2012).
O'Shea, R. & Moser, H. E. Physicochemical properties of antibacterial compounds: implications for drug discovery. J. Med. Chem. 51, 2871–2878 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Related links
Rights and permissions
About this article
Cite this article
Cooper, M. A community-based approach to new antibiotic discovery. Nat Rev Drug Discov 14, 587–588 (2015). https://doi.org/10.1038/nrd4706
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4706
This article is cited by
-
Nonribosomal antibacterial peptides isolated from Streptomyces agglomeratus 5-1-3 in the Qinghai-Tibet Plateau
Microbial Cell Factories (2023)
-
Isolation and identification of endophytic actinobacteria from Citrullus colocynthis (L.) Schrad and their antibacterial properties
Microbial Cell Factories (2022)
-
An appraisal of natural products active against parasitic nematodes of animals
Parasites & Vectors (2019)
-
Hürden und Aussichten neuer antimikrobieller Konzepte in Forschung und Entwicklung
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2018)
-
Antibiotics in the clinical pipeline at the end of 2015
The Journal of Antibiotics (2017)